Register
Login:
Share:
Email Facebook Twitter





Add Summit Ther to quick picks

Summit Ther Share Price (SUMM)



Share Price Information for Summit Ther (SUMM)


Share Price: 158.50Bid: 155.00Ask: 162.00Change: 1.00 (+0.63%)Riser - Summit Ther
Spread: 7.00Spread as %: 4.52%Open: 158.50High: 158.50Low: 158.50Yesterday’s Close: 157.50

Summit Therapeutics Plc Ord 1P

Summit Ther is listed in the FTSE AIM All-Share
Summit Ther is part of the Pharmaceuticals & Biotechnology sector






Share Price SpacerPrice
158.50

Share Price SpacerBid
155.00

Share Price SpacerAsk
162.00

Share Price SpacerChange
0.63%1.00

Share Price SpacerVolume
26,148

Share Price SpacerOpen
158.50

Share Price SpacerHigh
158.50

Share Price SpacerLow
158.50

Share Price SpacerClose
157.50

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 60.98m £96.66m 2,000

52 Week High 185.00 52 Week High Date 2-MAR-2015
52 Week Low 6.25 52 Week Low Date 27-MAY-2014

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
15 12,970 13,178 -5.319 -29.80 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

31-Mar-15
13:06:43
159.99
3,125
Buy* 
155.00
162.00
5,000
Trade Type:
Ordinary

31-Mar-15
12:27:05
160.00
6,242
Buy* 
155.00
162.00
9,987
Trade Type:
Ordinary

31-Mar-15
11:51:02
156.10
2,500
Sell* 
155.00
162.00
3,903
Trade Type:
Ordinary


*Buys and Sells are calculated on the difference between the trade price and the current mid price. As such, they can occasionally be incorrect.

View more Summit Ther trades >>

Directors Deals for Summit Ther (SUMM)
Trade DateActionNotifierPriceCurrencyAmountHolding
29-Jul-14Buy
Trade Notifier Information for Summit Corporation
Glyn Edwards held the position of CEO at Summit Corporation at the time of this trade.
 Glyn Edwards
104.5GBX30,000233333
23-Jul-13Placing
Trade Notifier Information for Summit Corporation
Frank Armstrong held the position of Non-Executive Director at Summit Corporation at the time of this trade.
 Frank Armstrong
5GBX50,00050000
23-Jul-13Placing
Trade Notifier Information for Summit Corporation
Jim Mellon held the position of Non-Executive Director at Summit Corporation at the time of this trade.
 Jim Mellon
5GBX20,000,00045000001
View more Summit Ther directors dealings >>

Date/Time
Author
Subject
Share Price
Opinion
Mon 23:57
Chrisatrdg
Great finish in US contd.
157.50
Strong Buy

Final NASDAQ close $12.25* 0.95 8.41% up Link below for the list of NASDAQ top risers per wingandaprayer: hTTp://www.nasdaq.com/markets/most-active.aspx#ADV
Mon 22:51
wingandaprayer
Great finish in US
157.50
No Opinion

Summit on list of NASDAQ top risers tonight.
Mon 16:03
GP68
Reason for SP increase ?
158.50
Strong Buy

Thank you Chrisatrdg..great find. Pretty impressive forecasts from these two that were involved in the placing. Oppenheimer $28 and outperform and Needham $22 Buy recommendations. GL
Mon 15:38
Chrisatrdg
Reason for SP increase ?
158.50
Strong Buy

Detailed below link to two SP forecasts out today which is the likely reason for todays SP increase: hTTp://www.investorvillage.com/groups.asp?mb=13685&mn=47700&pt=msg&mid=14808924
Mon 13:09
Chrisatrdg
NASDAQ Pre Trading up
155.50
Strong Buy

SMMT NASDAQ Pre Trading is up today: Summit Therapeutics plc (SMMT) Pre-Market Trading $12.30*8.85%
Mon 09:51
Admington
Trials
151.00
Buy

All very boring currently, which isn't necessarily bad, but seems a very long time from the heady days when the SP hit the equivalent of £4.00. I 'd be grateful if someone would remind me when we can expect to have the results of the 2 trials.

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Summit Ther (SUMM) >>
Please Login or Register to post messages






Sign up for Live Prices


CD02WL.001.081313


Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.